Dr. Beth Marlowe is the Executive Scientific Director and leads R&D for Quest Diagnostics Infectious Diseases and immunology. Dr Marlowe joined Quest in June of 2019.  Beginning January of 2020, her team played a key role in the SARS-CoV-2 response and in 2022 the Mpox response.

Dr Marlowe received PhD from the University Arizona in 1999.  She completed her postdoctoral fellowship in 2001 at the UCLA David Geffen School of Medicine. Following her postdoctoral fellowship, she continued at UCLA as an Adjunct Professor in the College of Medicine and as a Research Coordinator at the Wadsworth Anaerobe Laboratory at the West Los Angeles VA where her research focused on the microbiome of the autistic gut and the role of toxin producing anaerobes. In 2002, Dr. Marlowe joined Gen-Probe, Incorporated (now Hologic) with her primary research in the development of rapid molecular diagnostics for infectious diseases. From 2005 – 2016 she provided laboratory leadership within the Kaiser Permanente Regional Laboratories in both Southern California, as the Assistant Director, and Northern California, as Director of Microbiology. At Kaiser she oversaw the translational research program that included participation in over ten clinical trials. Prior to joining Quest she held the position of Global Director of Medical Affairs at Roche Molecular Systems from 2016-19 where she supported several global product launches.

She is a diplomat of the American Board of Medical Microbiology, past president for the So Cal branch of the American Society for Microbiology (ASM), past editor for the Clinical Microbiology Newsletter and the Journal of Clinical Virology. She has served as an elected member to the Council on Microbial Sciences and the Board of Directors for ASM. Dr Marlowe also served as a member of CLIAC, the federal advisory committee for CLIA to the United Stated Health and Human Services Secretary.

She has co-authored >100 articles, book chapters and abstracts. Her research areas of interest are focused on the translation of new infectious disease diagnostics for use in evidence-based research for clinical and public health microbiology practice.